.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Colorcon
Mallinckrodt
Federal Trade Commission
Merck
Medtronic
US Army
Queensland Health
Dow
McKesson

Generated: June 27, 2017

DrugPatentWatch Database Preview

Hydrochlorothiazide; reserpine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydrochlorothiazide; reserpine and what is the scope of hydrochlorothiazide; reserpine patent protection?

Hydrochlorothiazide; reserpine
is the generic ingredient in eleven branded drugs marketed by Sandoz, Roxane, Abc Holding, Watson Labs, Pharmeral, Whiteworth Town Plsn, Merck, Ivax Sub Teva Pharms, Novartis, Barr, and West Ward, and is included in twenty-three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for hydrochlorothiazide; reserpine.

Summary for Generic Name: hydrochlorothiazide; reserpine

Tradenames:11
Patents:1
Applicants:11
NDAs:23
Drug Master File Entries: see list31
Bulk Api Vendors: see list1
Clinical Trials: see list317
Drug Prices:see low prices
DailyMed Link:hydrochlorothiazide; reserpine at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane
HYDROCHLOROTHIAZIDE W/ RESERPINE
hydrochlorothiazide; reserpine
TABLET;ORAL084603-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Barr
RESERPINE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; reserpine
TABLET;ORAL084580-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Merck
HYDROPRES 25
hydrochlorothiazide; reserpine
TABLET;ORAL011958-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
HYDROCHLOROTHIAZIDE W/ RESERPINE
hydrochlorothiazide; reserpine
TABLET;ORAL085317-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sandoz
"HYDRO-SERP ""25"""
hydrochlorothiazide; reserpine
TABLET;ORAL084827-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
McKesson
QuintilesIMS
Cipla
Healthtrust
Mallinckrodt
Daiichi Sankyo
Novartis
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot